best glp-1 drug 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Researchers Move Closer to Matching
Description
In some cases, Import Alerts may be linked to Warning Letters for issues like manufacturing violations
High-risk medications include anticonvulsants, sulfonamide antibiotics, allopurinol, NSAIDs, nevirapine, and abacavir
While biological plausibility exists, clinicians should recognize that laboratory findings do not automatically translate into proven clinical benefit
Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study
GLp-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease
doi: 10.1212/WNL.0000000000005475
